Market Research Logo

Radiopharmaceutials/Nuclear Medicine Market Size, Share & Trend Analysis Report By Product (Diagnostics, Therapeutics) By Application, By Region (North America, APAC, Europe), And Segment Forecasts, 2018 - 2025

Radiopharmaceutials/Nuclear Medicine Market Size, Share & Trend Analysis Report By Product (Diagnostics, Therapeutics) By Application, By Region (North America, APAC, Europe), And Segment Forecasts, 2018 - 2025

The nuclear medicine market is expected to reach USD 13.8 billion by 2024, according to a new report by Grand View Research, Inc. The burden of chronic diseases such as cancer and cardiac disorders is on rise. Nuclear medicine products are widely used for diagnosis as well as treatment of cancerous and cardiovascular disease.

The increasing prevalence of these disorders poses direct impact on usage of radiopharmaceutical market. For instance, as per the data published by the World Health Organization (WHO), the incidences of cancer are anticipated to increase by 70.0% which is further anticipated to drive the demand for radiopharmaceuticals.

The diagnostics when combined with nuclear medicine improve on accuracy. The accuracy in the diagnosis has a direct impact on the decision-making and treatment monitoring process. Adoption of PET as a diagnostic tool is rapidly increasing since it has high accuracy over other diagnostic techniques.

Further key findings from the study suggest:

The product segments of nuclear medicine are divided into diagnostic and therapeutic. Diagnostic products held commanding share in 2015, this can be attributed to the advancements in scanning technologies.

Therapeutic products such as Alpha Emitters, Beta Emitters and Brachytherapy are anticipated to exhibit lucrative growth.

The key diagnostic application areas of nuclear medicine formed the largest market in 2015. These applications are in cardiology, neurology, oncology, and thyroid.

North America owing to well-planned policies, reimbursement structure, high healthcare spending and increasing awareness dominated global nuclear medicine market in 2015.

Asia Pacific is expected to witness lucrative growth in coming eight years. Increasing per capita income and reform in policies is favoring market players in terms of ease of doing business.

The players in the nuclear medicine industry include Eckert & Ziegler Group, Mallinckrodt Pharmaceuticals, GE Healthcare, Jubilant Life Sciences, Bracco Imaging S.p.A, Nordion, Inc.

Grand View Research has segmented the global nuclear medicine market on the basis of product and region:

Global Product Outlook (Revenue, USD Million, 2013 - 2024)

Diagnostics
SPECT

TC-99m

TL-201

GA-67

I-123

Others

PET

F-18

RB-82

Others

Therapeutics

Alpha Emitters

RA-223

Beta Emitters

I-131

Y-90

SM-153

Re-186

Lu-117

Others

Brachytherapy

Cesium-131

Iodine-125

Palladium-103

Iridium-192

Others

Regional Outlook (Revenue, USD Million, 2013 - 2024)

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

Japan

China

Latin America

Brazil

Mexico

MEA

South Africa


Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends & Scope
4.1 Market segmentation & scope
4.1.1 Market Driver Analysis
4.1.1.1 Rising incidence of cancer and cardiovascular disease
4.1.1.2 Widening applications of nuclear medicine
4.1.1.3 Growing demand for the accurate diagnostic methods
4.1.2 Market Restraint Analysis
4.1.2.1 Stringent regulation for production, storage, and usage
4.1.2.2 High costs involved in the procedure
4.2 Radiopharmecuticals - PESTLE Analysis
4.3 Industry Analysis - Porter’s
4.4 Penetration Index
Chapter 5 Nuclear Medicine Market Categorization: Product Estimates & Trend Analysis
5.1 Nuclear medicine market: Product movement analysis
5.2 Diagnostic products
5.2.1 Diagnostic products market, 2013 - 2024 (USD Million)
5.2.2 SPECT
5.2.2.1 SPECT products market, 2013 - 2024 (USD Million)
5.2.2.2 TC-99m
5.2.2.2.1 TC-99m market, 2013 - 2024 (USD Million)
5.2.2.3 TL-201
5.2.2.3.1 TL-201 market, 2013 - 2024 (USD Million)
5.2.2.4 GA-67
5.2.2.4.1 GA-67 market, 2013 - 2024 (USD Million)
5.2.2.5 I-123
5.2.2.5.1 I-123 market, 2013 - 2024 (USD Million)
5.2.2.6 Other SPECT products
5.2.2.6.1 Other SPECT products market, 2013 - 2024 (USD Million)
5.2.3 PET
5.2.3.1 PET products market, 2013 - 2024 (USD Million)
5.2.3.2 F-18
5.2.3.2.1 F-18 market, 2013 - 2024 (USD Million)
5.2.3.3 RB-82
5.2.3.3.1 RB-82 market, 2013 - 2024 (USD Million)
5.2.3.4 Other PET products
5.2.3.4.1 Other PET products market, 2013 - 2024 (USD Million)
5.3 Therapeutic products
5.3.1 Therapeutic products market, 2013 - 2024 (USD Million)
5.3.2 Alpha emitters
5.3.2.1 Alpha emitters market, 2013 - 2024 (USD Million)
5.3.2.2 RA-223
5.3.2.2.1 RA-223 market, 2013 - 2024 (USD Million)
5.3.2.3 Other alpha emitters
5.3.2.3.1 Other alpha emitters market, 2013 - 2024 (USD Million)
5.3.3 Beta emitters
5.3.3.1 Beta emitters market, 2013 - 2024 (USD Million)
5.3.3.2 I-131
5.3.3.2.1 I-131 market, 2013 - 2024 (USD Million)
5.3.3.3 Y-90
5.3.3.3.1 Y-90 market, 2013 - 2024 (USD Million)
5.3.3.4 SM-153
5.3.3.4.1 SM-153 market, 2013 - 2024 (USD Million)
5.3.3.5 Re-186
5.3.3.5.1 Re-186 market, 2013 - 2024 (USD Million)
5.3.3.6 Lu-117
5.3.3.6.1 Lu-117 market, 2013 - 2024 (USD Million)
5.3.3.7 Other beta emitters
5.3.3.7.1 Other beta emitters market, 2013 - 2024 (USD Million)
5.3.4 Brachytherapy
5.3.4.1 Brachytherapy market, 2013 - 2024 (USD Million)
5.3.4.2 Cesium-131
5.3.4.2.1 Cesium-131 market, 2013 - 2024 (USD Million)
5.3.4.3 Iodine-125
5.3.4.3.1 Iodine-125 market, 2013 - 2024 (USD Million)
5.3.4.4 Palladium-103
5.3.4.4.1 Palladium-103 market, 2013 - 2024 (USD Million)
5.3.4.5 Iridium-192
5.3.4.5.1 Iridium-192 market, 2013 - 2024 (USD Million)
5.3.4.6 Other brachytherapy products
5.3.4.6.1 Other brachytherapy products market, 2013 - 2024 (USD Million)
Chapter 6 Nuclear Medicine Market Categorization: Application Estimates & Trend Analysis
6.1 Nuclear medicine market: Application movement analysis
6.2 Diagnostic application
6.2.1 Diagnostic application market, 2013 - 2024 (USD Million)
6.2.2 Cardiology
6.2.2.1 Cardiology applications market, 2013 - 2024 (USD Million)
6.2.3 Neurology
6.2.3.1 Neurology applications market, 2013 - 2024 (USD Million)
6.2.4 Oncology
6.2.4.1 Oncology applications market, 2013 - 2024 (USD Million)
6.2.5 Thyroid
6.2.5.1 Thyroid applications market, 2013 - 2024 (USD Million)
6.2.6 Lymphoma
6.2.6.1 Lymphoma applications market, 2013 - 2024 (USD Million)
6.2.7 Other diagnostic application
6.2.7.1 Other diagnostic applications market, 2013 - 2024 (USD Million)
6.3 Therapeutic application
6.3.1 Therapeutic application market, 2013 - 2024 (USD Million)
6.3.2 Thyroid
6.3.2.1 Thyroid applications market, 2013 - 2024 (USD Million)
6.3.3 Bone metastasis
6.3.3.1 Bone metastasis applications market, 2013 - 2024 (USD Million)
6.3.4 Lymphoma
6.3.4.1 Lymphoma applications market, 2013 - 2024 (USD Million)
6.3.5 Endocrine tumor
6.3.5.1 Endocrine tumor market, 2013 - 2024 (USD Million)
6.3.6 Other therapeutic application
6.3.6.1 Other therapeutic applications market, 2013 - 2024 (USD Million)
Chapter 7 Nuclear Medicine Market Categorization: Regional Estimates & Trend Analysis, by Product and Application
7.1 Nuclear medicine market share by region, 2015& 2024
7.2 North America
7.2.1 North America nuclear medicine market, 2013 - 2024 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. nuclear medicine market, 2013 - 2024 (USD Million)
7.2.3 Canada
7.2.3.1 Canada nuclear medicine market, 2013 - 2024 (USD Million)
7.3 Europe
7.3.1 Europe nuclear medicine market, 2013 - 2024 (USD Million)
7.3.2 UK
7.3.2.1 UK nuclear medicine market, 2013 - 2024 (USD Million)
7.3.3 Germany
7.3.3.1 Germany nuclear medicine market, 2013 - 2024 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific nuclear medicine market, 2013 - 2024 (USD Million)
7.4.2 Japan
7.4.2.1 Japan nuclear medicine market, 2013 - 2024 (USD Million)
7.4.3 China
7.4.3.1 China nuclear medicine market, 2013 - 2024 (USD Million)
7.5 Latin America
7.5.1 Latin America nuclear medicine market, 2013 - 2024 (USD Million)
7.6 Brazil
7.6.1 Brazil nuclear medicine market, 2013 - 2024 (USD Million)
7.7 Mexico
7.7.1 Mexico nuclear medicine market, 2013 - 2024 (USD Million)
7.8 Middle East and Africa (MEA)
7.8.1 MEA nuclear medicine market, 2013 - 2024 (USD Million)
7.9 South Africa
7.9.1 South Africa nuclear medicine market, 2013 - 2024 (USD Million)
Chapter 8 Competitive Landscape
8.1 Eckert & Ziegler Group
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 Strategic Initiatives
8.2 Mallinckrodt public limited company
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.2.4 Strategic Initiatives
8.3 GE Healthcare
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Product Benchmarking
8.3.4 Strategic Initiatives
8.4 Jubilant Life Sciences
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiatives
8.5 Bracco Imaging S.p.A
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.5.4 Strategic Initiatives
8.6 Nordion, Inc.
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.6.4 Strategic Initiatives
8.7 The Institute for Radioelements (The IRE)
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.7.4 Strategic Initiatives
8.8 Australian Nuclear Science & Technology Organization (ANSTO)
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Product Benchmarking
8.9 NTP RadioisotopesSOC Ltd.
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiatives
8.10 Eczacibasi-Monrol
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Product Benchmarking
8.10.4 Strategic Initiatives
List of Tables
TABLE 1 North America nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 2 North America diagnostic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 3 North America SPECT market, by product,2013 - 2024 (USD Million)
TABLE 4 North America PET market, by product, 2013 - 2024 (USD Million)
TABLE 5 North America therapeutic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 6 North America alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 7 North America beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 8 North America brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 9 North America nuclear medicine market, by application, 2013 - 2024 (USD Million)
TABLE 10 North America diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 11 North America therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 12 U.S. nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 13 U.S. diagnostic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 14 U.S. SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 15 U.S. PET market, by product, 2013 - 2024 (USD Million)
TABLE 16 U.S. therapeutic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 17 U.S. alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 18 U.S. beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 19 U.S. brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 20 U.S. nuclear medicine market, by application, 2013 - 2024 (USD Million)
TABLE 21 U.S. diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 22 U.S. therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 23 Canada nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 24 Canada diagnostic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 25 Canada SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 26 Canada PET market, by product, 2013 - 2024 (USD Million)
TABLE 27 Canada therapeutic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 28 Canada alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 29 Canada beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 30 Canada brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 31 Canada nuclear medicine market, by application, 2013 - 2024 (USD Million)
TABLE 32 Canada diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 33 Canada therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 34 Europe nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 35 Europe diagnostic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 36 Europe SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 37 Europe PET market, by product, 2013 - 2024 (USD Million)
TABLE 38 Europe therapeutic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 39 Europe alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 40 Europe beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 41 Europe brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 42 Europe nuclear medicine market, by application, 2013 - 2024 (USD Million)
TABLE 43 Europe diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 44 Europe therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 45 UK nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 46 UK diagnostic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 47 UK SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 48 UK PET market, by product, 2013 - 2024 (USD Million)
TABLE 49 UK therapeutic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 50 UK alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 51 UK beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 52 UK brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 53 UK nuclear medicine market, by application, 2013 - 2024 (USD Million)
TABLE 54 UK diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 55 UK therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 56 Germany nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 57 Germany diagnostic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 58 Germany SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 59 Germany PET market, by product, 2013 - 2024 (USD Million)
TABLE 60 Germany therapeutic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 61 Germany alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 62 Germany beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 63 Germany brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 64 Germany nuclear medicine market, by application, 2013 - 2024 (USD Million)
TABLE 65 Germany diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 66 Germany therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 67 Asia Pacific nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 68 Asia Pacific diagnostic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 69 Asia Pacific SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 70 Asia Pacific PET market, by product, 2013 - 2024 (USD Million)
TABLE 71 Asia Pacific therapeutic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 72 Asia Pacific alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 73 Asia Pacific beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 74 Asia Pacific brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 75 Asia Pacific nuclear medicine market, by application, 2013 - 2024 (USD Million)
TABLE 76 Asia Pacific diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 77 Asia Pacific therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 78 Japan nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 79 Japan diagnostic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 80 Japan SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 81 Japan PET market, by product, 2013 - 2024 (USD Million)
TABLE 82 Japan therapeutic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 83 Japan alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 84 Japan beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 85 Japan brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 86 Japan nuclear medicine market, by application, 2013 - 2024 (USD Million)
TABLE 87 Japan diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 88 Japan therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 89 China nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 90 China diagnostic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 91 China SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 92 China PET market, by product, 2013 - 2024 (USD Million)
TABLE 93 China therapeutic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 94 China alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 95 China beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 96 China brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 97 China nuclear medicine market, by application, 2013 - 2024 (USD Million)
TABLE 98 China diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 99 China therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 100 Latin America nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 101 Latin America diagnostic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 102 Latin America SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 103 Latin America PET market, by product, 2013 - 2024 (USD Million)
TABLE 104 Latin America therapeutic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 105 Latin America alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 106 Latin America beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 107 Latin America brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 108 Latin America nuclear medicine market, by application, 2013 - 2024 (USD Million)
TABLE 109 Latin America diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 110 Latin America therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 111 Brazil nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 112 Brazil diagnostic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 113 Brazil SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 114 Brazil PET market, by product, 2013 - 2024 (USD Million)
TABLE 115 Brazil therapeutic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 116 Brazil alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 117 Brazil beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 118 Brazil brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 119 Brazil nuclear medicine market, by application, 2013 - 2024 (USD Million)
TABLE 120 Brazil diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 121 Brazil therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 122 Mexico nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 123 Mexico diagnostic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 124 Mexico SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 125 Mexico PET market, by product, 2013 - 2024 (USD Million)
TABLE 126 Mexico therapeutic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 127 Mexico alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 128 Mexico beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 129 Mexico brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 130 Mexico nuclear medicine market, by application, 2013 - 2024 (USD Million)
TABLE 131 Mexico diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 132 Mexico therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 133 MEA nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 134 MEA diagnostic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 135 MEA SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 136 MEA PET market, by product, 2013 - 2024 (USD Million)
TABLE 137 MEA therapeutic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 138 MEA alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 139 MEA beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 140 MEA brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 141 MEA nuclear medicine market, by application, 2013 - 2024 (USD Million)
TABLE 142 MEA diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 143 MEA therapeutic application market, by type, 2013 - 2024 (USD Million)
TABLE 144 South Africa nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 145 South Africa diagnostic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 146 South Africa SPECT market, by product, 2013 - 2024 (USD Million)
TABLE 147 South Africa PET market, by product, 2013 - 2024 (USD Million)
TABLE 148 South Africa therapeutic nuclear medicine market, by product, 2013 - 2024 (USD Million)
TABLE 149 South Africa alpha emitters market, by product, 2013 - 2024 (USD Million)
TABLE 150 South Africa beta emitters market, by product, 2013 - 2024 (USD Million)
TABLE 151 South Africa brachytherapy market, by product, 2013 - 2024 (USD Million)
TABLE 152 South Africa nuclear medicine market, by application, 2013 - 2024 (USD Million)
TABLE 153 South Africa diagnostic application market, by type, 2013 - 2024 (USD Million)
TABLE 154 South Africa therapeutic application market, by type, 2013 - 2024 (USD Million)
List of Figures
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary (USD Million, 2015)
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Global Cancer Prevalence projection, 2015-2024 (Number of registered cases)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Nuclear medicine PESTLE Analysis
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Penetration Index
FIG. 16 Nuclear medicine market product outlook key takeaways
FIG. 17 Nuclear medicine market: Product movement analysis
FIG. 18 Diagnostic products market, 2013 - 2024 (USD Million)
FIG. 19 SPECT products market, 2013 - 2024 (USD Million)
FIG. 20 TC-99m market, 2013 - 2024 (USD Million)
FIG. 21 TL-201 market, 2013 - 2024 (USD Million)
FIG. 22 GA-67 market, 2013 - 2024 (USD Million)
FIG. 23 I-123 market, 2013 - 2024 (USD Million)
FIG. 24 Other SPECT products market, 2013 - 2024 (USD Million)
FIG. 25 PET products market, 2013 - 2024 (USD Million)
FIG. 26 F-18 market, 2013 - 2024 (USD Million)
FIG. 27 RB-82 market, 2013 - 2024 (USD Million)
FIG. 28 Other PET products market, 2013 - 2024 (USD Million)
FIG. 29 Therapeutic products market, 2013 - 2024 (USD Million)
FIG. 30 Alpha emitters market, 2013 - 2024 (USD Million)
FIG. 31 RA-223 market, 2013 - 2024 (USD Million)
FIG. 32 Other alpha emitters market, 2013 - 2024 (USD Million)
FIG. 33 Beta emitters market, 2013 - 2024 (USD Million)
FIG. 34 I-131 market, 2013 - 2024 (USD Million)
FIG. 35 Y-90 market, 2013 - 2024 (USD Million)
FIG. 36 SM-153 market, 2013 - 2024 (USD Million)
FIG. 37 Re-186 market, 2013 - 2024 (USD Million)
FIG. 38 Lu-117 market, 2013 - 2024 (USD Million)
FIG. 39 Other beta emitters market, 2013 - 2024 (USD Million)
FIG. 40 Brachytherapy market, 2013 - 2024 (USD Million)
FIG. 41 Cesium-131 market, 2013 - 2024 (USD Million)
FIG. 42 Iodine-125 market, 2013 - 2024 (USD Million)
FIG. 43 Palladium-103 market, 2013 - 2024 (USD Million)
FIG. 44 Iridium-192 market, 2013 - 2024 (USD Million)
FIG. 45 Other brachytherapy products market, 2013 - 2024 (USD Million)
FIG. 46 Nuclear medicine market application outlook key takeaways
FIG. 47 Nuclear medicine market: Application movement analysis
FIG. 48 Diagnostic application market, 2013 - 2024 (USD Million)
FIG. 49 Cardiology applications market, 2013 - 2024 (USD Million)
FIG. 50 Neurology applications market, 2013 - 2024 (USD Million)
FIG. 51 Oncology applications market, 2013 - 2024 (USD Million)
FIG. 52 Thyroid applications market, 2013 - 2024 (USD Million)
FIG. 53 Lymphoma applications market, 2013 - 2024 (USD Million)
FIG. 54 Other diagnostic applications market, 2013 - 2024 (USD Million)
FIG. 55 Therapeutic application market, 2013 - 2024 (USD Million)
FIG. 56 Thyroid applications market, 2013 - 2024 (USD Million)
FIG. 57 Bone metastasis applications market, 2013 - 2024 (USD Million)
FIG. 58 Lymphoma applications market, 2013 - 2024 (USD Million)
FIG. 59 Endocrine tumor market, 2013 - 2024 (USD Million)
FIG. 60 Other therapeutic applications market, 2013 - 2024 (USD Million)
FIG. 61 Regional market place: Key takeaways
FIG. 62 Regional outlook, 2015 & 2024
FIG. 63 North America nuclear medicine market, 2013 - 2024 (USD Million)
FIG. 64 U.S. nuclear medicine market, 2013 - 2024 (USD Million)
FIG. 65 Canada nuclear medicine market, 2013 - 2024 (USD Million)
FIG. 66 Europe nuclear medicine market, 2013 - 2024 (USD Million)
FIG. 67 UK nuclear medicine market, 2013 - 2024 (USD Million)
FIG. 68 Germany nuclear medicine market, 2013 - 2024 (USD Million)
FIG. 69 Asia Pacific nuclear medicine market, 2013 - 2024 (USD Million)
FIG. 70 Japan nuclear medicine market, 2013 - 2024 (USD Million)
FIG. 71 China nuclear medicine market, 2013 - 2024 (USD Million)
FIG. 72 Latin America nuclear medicine market, 2013 - 2024 (USD Million)
FIG. 73 Brazil nuclear medicine market, 2013 - 2024 (USD Million)
FIG. 74 Mexico nuclear medicine market, 2013 - 2024 (USD Million)
FIG. 75 MEA nuclear medicine market, 2013 - 2024 (USD Million)
FIG. 76 South Africa nuclear medicine market, 2013 - 2024 (USD Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report